|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lennox-Gastaut Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| topiramate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Obesity Agents | |||||
| Anticonvulsants | |||||
| Central Nervous System Agents | |||||
| Neuroprotective Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| University of California, Los Angeles | |||||